Variable | rhGH group (n = 23) | Control group (n = 20) | P value |
---|---|---|---|
Age (yr) | 11.61(1.73) | 11.25(1.86) | 0.516 |
Male/Female (n) | 21/2 | 19/1 | 0.635 |
Prepuberty/Puberty, (n) | 16/7 | 14/6 | 0.975 |
BMI SDS | 2.64(0.74) | 2.73(0.71) | 0.676 |
BA-CA(yr) | 1.43(1.88) | 1.32(1.63) | 0.826 |
Peak stimulated GH(μg/L) | 1.8(1.2-3.7) | 1.75(1.23-3.35) | 0.761▲ |
IGF-1(ng/ml) | 241.47(105.98) | 291.1(151.95) | 0.321# |
TC(mmol/L) | 4.81(0.65) | 4.34(1.05) | 0.093 |
HDL-C (mmol/L) | 1.32(0.39) | 1.22(0.22) | 0.405# |
LDL-C (mmol/L) | 2.87(0.47) | 2.58(0.85) | 0.084# |
TG(mmol/L) | 1.49(0.76) | 1.22(0.38) | 0.326# |
ALT(U/L) | 22(15-64) | 23(16.25-68.75) | 0.567▲ |
AST(U/L) | 25(22-32) | 26.5(20.25-46.25) | 1▲ |
Insulin(uIU/mL) | 28.32(17.23) | 27.92(16.73) | 0.807# |
FBG(mmol/L) | 5.21(0.43) | 5.12(0.43) | 0.527▲ |
HOMA-IR | 6.63(4.35) | 6.38(3.92) | 0.746# |
HbA1c (%) | 5.7(5.4-5.9) | 5,6(5.325-5.875) | 0.448 |